Tag Archives: 64

Cipla restrained to make generic COPD drug: DHC

The Delhi High Court restrained domestic pharma company Cipla from producing and marketing a generic version of Novartis drug ‘Onbrez’ used for treating Chronic Obstructive Pulmonary Disease. Novartis sued Cipla for infringement of its Indian patents for drug ‘Onbrez’ containing Indacaterol … Continue reading

Posted in Intellectual Property Law, International Law, patent law, Trade Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Glenmark restrained from producing anti-diabetic drug: DHC

The Delhi High Court restrained Glenmark Pharmaceuticals from producing and marketing a generic version of Merck’s drug ‘Januvia’ used for treating diabetes. Merck sued Glenmark for infringement of its Indian patent for ‘Januvia’ and ‘Janumet’. Glenmark was selling the generic version … Continue reading

Posted in Intellectual Property Law, International Law, patent, trademark | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Parties not allowed to raise same issue before multiple forums: SC

In an important ruling, the Supreme Court of India clarified that a party seeking revocation of a patent should not be allowed to raise the same issue before different adjudicating forums, and in case of such multiple filings the appropriate … Continue reading

Posted in Civil Law, General Law, Intellectual Property Law, International Law | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment